They're very much pushing the combined trial strategy.
A risk, in the sense that the companies SP narrative is tied to the success of that.
I really hope it works, and if it does I can see the SP taking off, but if it backfires, then we are in for more pain...
Cash burn is very impressive, run on an oily rag, so I feel confident that management are giving this every chance of success and that it isn't just some director fee play thing.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38792 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 4000 | 1 |
View Market Depth
| Last trade - 07.00am 23/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable